Filename: FOI.ICB-2526_157-BEVACIZUMAB-GAMMA-FINAL-RESPONSE.PDF
File type: PDF
File size: 289 KB
FOI.ICB-2526/157: Bevacizumab Gamma (Lytenava®) for Neovascular (wet) Age-related Macular Degeneration (NICE TA1022)